Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,012 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios.
Hoogendoorn M, Feenstra T, Asukai Y, Borg S, Hansen RN, Jansson SA, Samyshkin Y, Wacker M, Briggs A, Lloyd A, Sullivan SD, Rutten-van Mölken MP. Hoogendoorn M, et al. Among authors: briggs a. Value Health. 2014 Nov;17(7):A557-8. doi: 10.1016/j.jval.2014.08.1836. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201829 Free article. No abstract available.
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Hoogendoorn M, Feenstra TL, Asukai Y, Briggs AH, Borg S, Dal Negro RW, Hansen RN, Jansson SA, Leidl R, Risebrough N, Samyshkin Y, Wacker ME, Rutten-van Mölken MPMH. Hoogendoorn M, et al. Value Health. 2016 Sep-Oct;19(6):800-810. doi: 10.1016/j.jval.2016.04.002. Epub 2016 May 21. Value Health. 2016. PMID: 27712708 Free article.
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Hoogendoorn M, Feenstra TL, Asukai Y, Borg S, Hansen RN, Jansson SA, Samyshkin Y, Wacker M, Briggs AH, Lloyd A, Sullivan SD, Rutten-van Mölken MP. Hoogendoorn M, et al. Among authors: briggs ah. Value Health. 2014 Jul;17(5):525-36. doi: 10.1016/j.jval.2014.03.1721. Epub 2014 May 14. Value Health. 2014. PMID: 25128045 Free article.
Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources.
Hoogendoorn M, Feenstra TL, Boland M, Briggs AH, Borg S, Jansson SA, Risebrough NA, Slejko JF, Rutten-van Mölken MP. Hoogendoorn M, et al. Among authors: briggs ah. Int J Chron Obstruct Pulmon Dis. 2017 Nov 1;12:3183-3194. doi: 10.2147/COPD.S142378. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29138546 Free PMC article.
Validating A Model To Predict Disease Progression Outcomes In Patients With COPD.
Risebrough NA, Briggs A, Baker TM, Exuzides A, Colby C, Rutten van-Molken M, Gonzalez McQuire S, Lomas D, Muellerova H, Tal-Singer R, Ismaila A. Risebrough NA, et al. Among authors: briggs a. Value Health. 2014 Nov;17(7):A560-1. doi: 10.1016/j.jval.2014.08.1852. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201846 Free article. No abstract available.
1,012 results